1.71
price up icon6.87%   0.11
pre-market  시장 영업 전:  1.71  
loading

왜 Erasca Inc (ERAS) 주가가 하락하고 있습니까?

2025-09-03 거래 세션 동안 Erasca Inc(ERAS) 주식이 10.63% 하락한 것을 확인했습니다. 이는 정상적인 변동성이나 다양한 내부 및 외부 요인에 의한 것일 수 있지만, 상황을 적극적으로 모니터링하고 있으며 최대한 빨리 적시에 업데이트를 제공하도록 하겠습니다!
2023-11-28:

Shares of Erasca Inc (ERAS) dropped by 11.38% from $2.24 to $1.99 in the trading on Tuesday, November 28, 2023. The reason why ERAS is down today is due to the company's program updates, particularly regarding its SEACRAFT-2 Phase 3 trial for Naporafenib Plus Trametinib and its THUNDERBBOLT-1 Phase 1 trial for ERAS-801. Investors may have been concerned about the trial details, including the patient population and comparator arm in SEACRAFT-2, as well as the need for additional data for ERAS-801. Additionally, the company's decision to deprioritize certain programs and focus on more promising initiatives could have contributed to the stock's decline.

$35.42
price up icon 0.77%
$83.90
price up icon 0.91%
$28.24
price up icon 0.89%
$99.26
price up icon 1.41%
$144.75
price up icon 1.12%
biotechnology ONC
$327.20
price down icon 1.53%
자본화:     |  볼륨(24시간):